Overview

Efficacy and Safety Study of Tazarotene (Tazorac) for the Treatment of Brittle Nails

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether topical tazarotene (Tazorac), a receptor-selective synthetic retinoid that normalizes epidermal differentiation, ameliorates signs and symptoms of brittle nails.
Phase:
Phase 4
Details
Lead Sponsor:
Columbia University
Collaborator:
Allergan
Treatments:
Nicotinic Acids
Tazarotene